# Pharmacokinetics of Ethionamide and Ethionamide Sulfoxide in Patients Established on Treatment for Tuberculosis.

> **NCT05258877** · — · COMPLETED · sponsor: **BioVersys AG** · enrollment: 30 (actual)

## Conditions studied

- Tuberculosis, Pulmonary

## Interventions

- **OTHER:** Plasma samples

## Key facts

- **NCT ID:** NCT05258877
- **Lead sponsor:** BioVersys AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-10
- **Primary completion:** 2023-09-28
- **Final completion:** 2023-09-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05258877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05258877, "Pharmacokinetics of Ethionamide and Ethionamide Sulfoxide in Patients Established on Treatment for Tuberculosis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05258877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*